Sun Pharmaceutical Industries Q2 Results

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs

1,191.40 -5.00 (-0.42%)Updated : 28 Nov 2023

Fiscal Period	2024
Period End Date	Sep 23
Revenue	12192.41
Total Revenue	12192.41
Costof Revenue Total	2787.09
Gross Profit	9405.32
Selling/ General/ Admin Expenses Total	2364.36
Depreciation/ Amortization	632.82
Unusual Expense( Income)	0.00
Other Operating Expenses Total	3827.49
Total Operating Expense	9611.76
Operating Income	2580.65
Interest Inc( Exp) Net- Non- Op Total	-833.80
Other Net	293.61
Net Income Before Taxes	2790.88
Provisionfor Income Taxes	390.10
Net Income After Taxes	2400.78
Minority Interest	-9.59
Equity In Affiliates	-156.80
Net Income Before Extra Items	2375.51
Net Income	2375.51
Income Availableto Com Excl Extra Ord	2375.51
Income Availableto Com Incl Extra Ord	2375.51
Diluted Net Income	2375.51
Diluted Weighted Average Shares	239.95
Diluted EPS Excluding Extra Ord Items	9.90
DPS- Common Stock Primary Issue	0.00
Diluted Normalized EPS	9.90